nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluridine—Nucleic Acid Synthesis Inhibitors—Capecitabine—prostate cancer	0.5	1	CiPCiCtD
Trifluridine—TYMS—prostate cancer	0.188	1	CbGaD
Trifluridine—TYMP—Capecitabine—prostate cancer	0.155	0.621	CbGbCtD
Trifluridine—TYMS—Capecitabine—prostate cancer	0.0827	0.33	CbGbCtD
Trifluridine—SLC22A6—Conjugated Estrogens—prostate cancer	0.0123	0.0492	CbGbCtD
Trifluridine—TK1—epithelium—prostate cancer	0.00186	0.145	CbGeAlD
Trifluridine—TYMP—prostate gland—prostate cancer	0.00135	0.105	CbGeAlD
Trifluridine—TK1—bone marrow—prostate cancer	0.00131	0.102	CbGeAlD
Trifluridine—TYMS—prostate gland—prostate cancer	0.00116	0.0902	CbGeAlD
Trifluridine—TYMP—seminal vesicle—prostate cancer	0.00114	0.0889	CbGeAlD
Trifluridine—TK1—testis—prostate cancer	0.00112	0.0869	CbGeAlD
Trifluridine—TYMP—urethra—prostate cancer	0.000904	0.0704	CbGeAlD
Trifluridine—TK1—lymph node—prostate cancer	0.000809	0.063	CbGeAlD
Trifluridine—TYMP—bone marrow—prostate cancer	0.000696	0.0542	CbGeAlD
Trifluridine—TYMS—Docetaxel—Cabazitaxel—prostate cancer	0.000616	0.349	CbGdCrCtD
Trifluridine—TYMS—bone marrow—prostate cancer	0.000597	0.0465	CbGeAlD
Trifluridine—TYMP—testis—prostate cancer	0.000595	0.0463	CbGeAlD
Trifluridine—TYMS—testis—prostate cancer	0.00051	0.0397	CbGeAlD
Trifluridine—Decitabine—DNMT1—prostate cancer	0.000466	0.276	CrCbGaD
Trifluridine—Zidovudine—TERT—prostate cancer	0.000445	0.264	CrCbGaD
Trifluridine—TYMP—lymph node—prostate cancer	0.000431	0.0336	CbGeAlD
Trifluridine—TYMS—Paclitaxel—Cabazitaxel—prostate cancer	0.000425	0.241	CbGdCrCtD
Trifluridine—Floxuridine—TYMS—prostate cancer	0.00038	0.225	CrCbGaD
Trifluridine—TYMS—lymph node—prostate cancer	0.00037	0.0288	CbGeAlD
Trifluridine—Punctate keratitis—Capecitabine—prostate cancer	0.000215	0.0808	CcSEcCtD
Trifluridine—TYMS—Paclitaxel—Docetaxel—prostate cancer	0.000177	0.1	CbGdCrCtD
Trifluridine—Eyelid oedema—Estradiol—prostate cancer	0.000172	0.0649	CcSEcCtD
Trifluridine—Zidovudine—CYP2A6—prostate cancer	0.00013	0.0772	CrCbGaD
Trifluridine—Cladribine—SLC22A1—prostate cancer	0.000118	0.0696	CrCbGaD
Trifluridine—TYMS—Podofilox—Etoposide—prostate cancer	0.000113	0.0642	CbGdCrCtD
Trifluridine—TYMS—Levorphanol—Estrone—prostate cancer	0.000112	0.0636	CbGdCrCtD
Trifluridine—Intraocular pressure increased—Prednisone—prostate cancer	0.00011	0.0414	CcSEcCtD
Trifluridine—Dry eye—Goserelin—prostate cancer	0.000101	0.0382	CcSEcCtD
Trifluridine—Zidovudine—CYP2C19—prostate cancer	9.16e-05	0.0543	CrCbGaD
Trifluridine—TYMS—Levorphanol—Estradiol—prostate cancer	8.51e-05	0.0482	CbGdCrCtD
Trifluridine—Vision blurred—Degarelix—prostate cancer	8.04e-05	0.0303	CcSEcCtD
Trifluridine—Dry eye—Estradiol—prostate cancer	8.04e-05	0.0302	CcSEcCtD
Trifluridine—Pain—Estrone—prostate cancer	7.18e-05	0.027	CcSEcCtD
Trifluridine—Pain—Nilutamide—prostate cancer	6.67e-05	0.0251	CcSEcCtD
Trifluridine—Pain—Estradiol valerate/Dienogest—prostate cancer	6.27e-05	0.0236	CcSEcCtD
Trifluridine—Pain—Degarelix—prostate cancer	5.96e-05	0.0224	CcSEcCtD
Trifluridine—Zidovudine—CYP3A4—prostate cancer	5.83e-05	0.0345	CrCbGaD
Trifluridine—TYMS—Danazol—Ethinyl Estradiol—prostate cancer	5.62e-05	0.0318	CbGdCrCtD
Trifluridine—Pain—Cabazitaxel—prostate cancer	5.61e-05	0.0211	CcSEcCtD
Trifluridine—Hypersensitivity—Estradiol valerate/Dienogest—prostate cancer	5.4e-05	0.0203	CcSEcCtD
Trifluridine—Nausea—Estramustine—prostate cancer	5.22e-05	0.0196	CcSEcCtD
Trifluridine—Hypersensitivity—Degarelix—prostate cancer	5.13e-05	0.0193	CcSEcCtD
Trifluridine—Dry eye—Capecitabine—prostate cancer	5.01e-05	0.0189	CcSEcCtD
Trifluridine—Nausea—Estrone—prostate cancer	4.99e-05	0.0188	CcSEcCtD
Trifluridine—Hypersensitivity—Cabazitaxel—prostate cancer	4.83e-05	0.0182	CcSEcCtD
Trifluridine—Pain—Bicalutamide—prostate cancer	4.81e-05	0.0181	CcSEcCtD
Trifluridine—Stinging—Epirubicin—prostate cancer	4.67e-05	0.0176	CcSEcCtD
Trifluridine—Nausea—Nilutamide—prostate cancer	4.63e-05	0.0174	CcSEcCtD
Trifluridine—Nausea—Flutamide—prostate cancer	4.61e-05	0.0174	CcSEcCtD
Trifluridine—Vision blurred—Goserelin—prostate cancer	4.52e-05	0.017	CcSEcCtD
Trifluridine—Vision blurred—Conjugated Estrogens—prostate cancer	4.48e-05	0.0169	CcSEcCtD
Trifluridine—Nausea—Estradiol valerate/Dienogest—prostate cancer	4.35e-05	0.0164	CcSEcCtD
Trifluridine—Stinging—Doxorubicin—prostate cancer	4.32e-05	0.0162	CcSEcCtD
Trifluridine—Hypersensitivity—Bicalutamide—prostate cancer	4.15e-05	0.0156	CcSEcCtD
Trifluridine—Nausea—Degarelix—prostate cancer	4.14e-05	0.0156	CcSEcCtD
Trifluridine—TYMS—Levonorgestrel—Ethinyl Estradiol—prostate cancer	4.03e-05	0.0228	CbGdCrCtD
Trifluridine—Nausea—Cabazitaxel—prostate cancer	3.9e-05	0.0147	CcSEcCtD
Trifluridine—Hypersensitivity—Ethinyl Estradiol—prostate cancer	3.51e-05	0.0132	CcSEcCtD
Trifluridine—Dry eye—Epirubicin—prostate cancer	3.49e-05	0.0131	CcSEcCtD
Trifluridine—Pain—Goserelin—prostate cancer	3.35e-05	0.0126	CcSEcCtD
Trifluridine—Nausea—Bicalutamide—prostate cancer	3.34e-05	0.0126	CcSEcCtD
Trifluridine—Vision blurred—Mitoxantrone—prostate cancer	3.34e-05	0.0126	CcSEcCtD
Trifluridine—Pain—Conjugated Estrogens—prostate cancer	3.32e-05	0.0125	CcSEcCtD
Trifluridine—Dry eye—Doxorubicin—prostate cancer	3.23e-05	0.0122	CcSEcCtD
Trifluridine—Hypersensitivity—Goserelin—prostate cancer	2.89e-05	0.0109	CcSEcCtD
Trifluridine—Hypersensitivity—Conjugated Estrogens—prostate cancer	2.86e-05	0.0108	CcSEcCtD
Trifluridine—Nausea—Ethinyl Estradiol—prostate cancer	2.83e-05	0.0106	CcSEcCtD
Trifluridine—Pain—Estradiol—prostate cancer	2.65e-05	0.00999	CcSEcCtD
Trifluridine—TYMS—Cell Cycle—MAD1L1—prostate cancer	2.65e-05	0.000623	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—EGF—prostate cancer	2.64e-05	0.000623	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—GSTM3—prostate cancer	2.61e-05	0.000615	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—NAGLU—prostate cancer	2.61e-05	0.000615	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—SULT2B1—prostate cancer	2.61e-05	0.000615	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—RFK—prostate cancer	2.61e-05	0.000615	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PGAM2—prostate cancer	2.61e-05	0.000615	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—MBTPS1—prostate cancer	2.61e-05	0.000615	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—AOX1—prostate cancer	2.61e-05	0.000615	CbGpPWpGaD
Trifluridine—TYMS—Clobetasol propionate—Prednisone—prostate cancer	2.61e-05	0.0148	CbGdCrCtD
Trifluridine—TYMS—Flunisolide—Prednisone—prostate cancer	2.58e-05	0.0146	CbGdCrCtD
Trifluridine—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	2.58e-05	0.000607	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—TOP2A—prostate cancer	2.57e-05	0.000604	CbGpPWpGaD
Trifluridine—TK1—Metabolism—SLC5A5—prostate cancer	2.55e-05	0.000601	CbGpPWpGaD
Trifluridine—TYMS—Triamcinolone—Prednisone—prostate cancer	2.55e-05	0.0144	CbGdCrCtD
Trifluridine—TYMP—Metabolism—PLCB2—prostate cancer	2.54e-05	0.000599	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—LRP2—prostate cancer	2.54e-05	0.000599	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—CYP2C18—prostate cancer	2.54e-05	0.000599	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—CDKN1B—prostate cancer	2.54e-05	0.000598	CbGpPWpGaD
Trifluridine—TK1—Metabolism—CYP2E1—prostate cancer	2.49e-05	0.000587	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—P4HB—prostate cancer	2.49e-05	0.000587	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—CREBBP—prostate cancer	2.48e-05	0.000584	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—AMACR—prostate cancer	2.48e-05	0.000583	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—CYP3A43—prostate cancer	2.48e-05	0.000583	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—NAT1—prostate cancer	2.48e-05	0.000583	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—SRD5A2—prostate cancer	2.48e-05	0.000583	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—DEGS1—prostate cancer	2.48e-05	0.000583	CbGpPWpGaD
Trifluridine—Pain—Mitoxantrone—prostate cancer	2.47e-05	0.00931	CcSEcCtD
Trifluridine—TK1—Metabolism—NQO1—prostate cancer	2.47e-05	0.000581	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—GSK3B—prostate cancer	2.46e-05	0.000581	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—IGF1—prostate cancer	2.45e-05	0.000577	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—AURKA—prostate cancer	2.45e-05	0.000577	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—NBN—prostate cancer	2.43e-05	0.000573	CbGpPWpGaD
Trifluridine—TK1—Metabolism—TH—prostate cancer	2.43e-05	0.000572	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—SLC22A1—prostate cancer	2.43e-05	0.000571	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—CCND1—prostate cancer	2.42e-05	0.000571	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—MLH1—prostate cancer	2.42e-05	0.00057	CbGpPWpGaD
Trifluridine—TK1—Metabolism—CYP3A4—prostate cancer	2.4e-05	0.000566	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—MAP2K1—prostate cancer	2.37e-05	0.000558	CbGpPWpGaD
Trifluridine—TK1—Metabolism—CYP1B1—prostate cancer	2.36e-05	0.000557	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—SULT2A1—prostate cancer	2.36e-05	0.000557	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—HSD17B1—prostate cancer	2.36e-05	0.000556	CbGpPWpGaD
Trifluridine—TYMS—Diflorasone—Prednisone—prostate cancer	2.35e-05	0.0133	CbGdCrCtD
Trifluridine—TYMS—Mitotic G1-G1/S phases—CDKN1A—prostate cancer	2.34e-05	0.000552	CbGpPWpGaD
Trifluridine—Nausea—Goserelin—prostate cancer	2.33e-05	0.00875	CcSEcCtD
Trifluridine—TYMP—Metabolism—MED12—prostate cancer	2.33e-05	0.000548	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—GNG5—prostate cancer	2.31e-05	0.000543	CbGpPWpGaD
Trifluridine—TYMS—G1/S Transition—MYC—prostate cancer	2.31e-05	0.000543	CbGpPWpGaD
Trifluridine—Nausea—Conjugated Estrogens—prostate cancer	2.3e-05	0.00867	CcSEcCtD
Trifluridine—TYMS—Cell Cycle—TOP2A—prostate cancer	2.29e-05	0.00054	CbGpPWpGaD
Trifluridine—TK1—Metabolism—GGT1—prostate cancer	2.29e-05	0.000539	CbGpPWpGaD
Trifluridine—Hypersensitivity—Estradiol—prostate cancer	2.29e-05	0.00861	CcSEcCtD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—TP53—prostate cancer	2.27e-05	0.000534	CbGpPWpGaD
Trifluridine—TK1—Metabolism—NCOA1—prostate cancer	2.25e-05	0.000531	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—FGF2—prostate cancer	2.25e-05	0.00053	CbGpPWpGaD
Trifluridine—Vision blurred—Capecitabine—prostate cancer	2.24e-05	0.00841	CcSEcCtD
Trifluridine—TYMS—Circadian rythm related genes—SERPINE1—prostate cancer	2.23e-05	0.000526	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—NCOA3—prostate cancer	2.22e-05	0.000523	CbGpPWpGaD
Trifluridine—TK1—Metabolism—CYP19A1—prostate cancer	2.22e-05	0.000523	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—SLC22A3—prostate cancer	2.2e-05	0.000519	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—AURKA—prostate cancer	2.19e-05	0.000516	CbGpPWpGaD
Trifluridine—TK1—Metabolism—RXRA—prostate cancer	2.14e-05	0.000505	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—BCL2—prostate cancer	2.14e-05	0.000504	CbGpPWpGaD
Trifluridine—Hypersensitivity—Mitoxantrone—prostate cancer	2.13e-05	0.00802	CcSEcCtD
Trifluridine—TYMS—Cell Cycle, Mitotic—APEX1—prostate cancer	2.13e-05	0.000501	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—HPGDS—prostate cancer	2.12e-05	0.000499	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—MDM2—prostate cancer	2.11e-05	0.000496	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—CYP2C19—prostate cancer	2.11e-05	0.000496	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—HPGD—prostate cancer	2.1e-05	0.000496	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—B4GALT4—prostate cancer	2.1e-05	0.000496	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—prostate cancer	2.08e-05	0.000489	CbGpPWpGaD
Trifluridine—TK1—Metabolism—COMT—prostate cancer	2.07e-05	0.000487	CbGpPWpGaD
Trifluridine—TYMS—Budesonide—Prednisone—prostate cancer	2.06e-05	0.0117	CbGdCrCtD
Trifluridine—Pain—Etoposide—prostate cancer	2.06e-05	0.00774	CcSEcCtD
Trifluridine—TYMP—Metabolism—GSTT1—prostate cancer	2.06e-05	0.000484	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—ACHE—prostate cancer	2.06e-05	0.000484	CbGpPWpGaD
Trifluridine—TK1—Metabolism—GSTP1—prostate cancer	2.06e-05	0.000484	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—CCND2—prostate cancer	2.05e-05	0.000483	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—CYP2A6—prostate cancer	2.03e-05	0.000479	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—ABCG5—prostate cancer	2.03e-05	0.000479	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—prostate cancer	2.03e-05	0.000478	CbGpPWpGaD
Trifluridine—TK1—Metabolism—ITPR1—prostate cancer	2.02e-05	0.000477	CbGpPWpGaD
Trifluridine—Vision blurred—Prednisone—prostate cancer	1.99e-05	0.00749	CcSEcCtD
Trifluridine—TYMS—Metabolism—TNFRSF21—prostate cancer	1.98e-05	0.000466	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—AKR1C3—prostate cancer	1.98e-05	0.000466	CbGpPWpGaD
Trifluridine—TYMS—Danazol—Prednisone—prostate cancer	1.97e-05	0.0112	CbGdCrCtD
Trifluridine—TYMP—Metabolism—PRKACB—prostate cancer	1.97e-05	0.000463	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—CHEK2—prostate cancer	1.96e-05	0.000461	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—CYP17A1—prostate cancer	1.95e-05	0.000459	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—MYC—prostate cancer	1.94e-05	0.000458	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—CYP7B1—prostate cancer	1.93e-05	0.000454	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—MTAP—prostate cancer	1.93e-05	0.000454	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	1.92e-05	0.000453	CbGpPWpGaD
Trifluridine—TK1—Metabolism—TYMS—prostate cancer	1.91e-05	0.00045	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—APEX1—prostate cancer	1.9e-05	0.000448	CbGpPWpGaD
Trifluridine—TK1—Metabolism—GSTM1—prostate cancer	1.89e-05	0.000445	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	1.89e-05	0.000444	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—SRD5A1—prostate cancer	1.88e-05	0.000442	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—SULT1E1—prostate cancer	1.88e-05	0.000442	CbGpPWpGaD
Trifluridine—TK1—Metabolism—LPL—prostate cancer	1.85e-05	0.000437	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—NCOA2—prostate cancer	1.85e-05	0.000437	CbGpPWpGaD
Trifluridine—Nausea—Estradiol—prostate cancer	1.84e-05	0.00694	CcSEcCtD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	1.83e-05	0.000432	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—CCND2—prostate cancer	1.83e-05	0.000432	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—BRCA1—prostate cancer	1.83e-05	0.000432	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	1.82e-05	0.000428	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—SLC22A1—prostate cancer	1.79e-05	0.000423	CbGpPWpGaD
Trifluridine—TK1—Metabolism—CYP1A1—prostate cancer	1.79e-05	0.000422	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—ACSL4—prostate cancer	1.79e-05	0.000422	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—HSD17B3—prostate cancer	1.79e-05	0.000422	CbGpPWpGaD
Trifluridine—TK1—Metabolism—ERCC2—prostate cancer	1.78e-05	0.000418	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	1.78e-05	0.000418	CbGpPWpGaD
Trifluridine—Hypersensitivity—Etoposide—prostate cancer	1.77e-05	0.00667	CcSEcCtD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	1.77e-05	0.000417	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—SLC5A5—prostate cancer	1.77e-05	0.000417	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—CYP2E1—prostate cancer	1.73e-05	0.000407	CbGpPWpGaD
Trifluridine—Nausea—Mitoxantrone—prostate cancer	1.72e-05	0.00647	CcSEcCtD
Trifluridine—TYMS—Metabolism—ARG2—prostate cancer	1.72e-05	0.000404	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—UMPS—prostate cancer	1.72e-05	0.000404	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PHGDH—prostate cancer	1.72e-05	0.000404	CbGpPWpGaD
Trifluridine—Pain—Docetaxel—prostate cancer	1.71e-05	0.00644	CcSEcCtD
Trifluridine—TYMP—Metabolism—NQO1—prostate cancer	1.71e-05	0.000403	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—GNG5—prostate cancer	1.71e-05	0.000402	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—PTEN—prostate cancer	1.7e-05	0.000401	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	1.69e-05	0.000398	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—TH—prostate cancer	1.68e-05	0.000397	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—LDHB—prostate cancer	1.68e-05	0.000396	CbGpPWpGaD
Trifluridine—TK1—Metabolism—MTHFR—prostate cancer	1.67e-05	0.000393	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—CYP3A4—prostate cancer	1.67e-05	0.000393	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—BRCA2—prostate cancer	1.66e-05	0.000391	CbGpPWpGaD
Trifluridine—Pain—Capecitabine—prostate cancer	1.66e-05	0.00623	CcSEcCtD
Trifluridine—TYMS—Metabolism—CYP3A5—prostate cancer	1.65e-05	0.000389	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	1.64e-05	0.000387	CbGpPWpGaD
Trifluridine—TK1—Metabolism—PPARA—prostate cancer	1.64e-05	0.000386	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—CYP1B1—prostate cancer	1.64e-05	0.000386	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—EP300—prostate cancer	1.62e-05	0.000382	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	1.6e-05	0.000377	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PDHA1—prostate cancer	1.6e-05	0.000376	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—TCN2—prostate cancer	1.6e-05	0.000376	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—UCP3—prostate cancer	1.6e-05	0.000376	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—GSTA3—prostate cancer	1.6e-05	0.000376	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—GGT1—prostate cancer	1.59e-05	0.000374	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—NCOA1—prostate cancer	1.56e-05	0.000368	CbGpPWpGaD
Trifluridine—Vision blurred—Epirubicin—prostate cancer	1.56e-05	0.00586	CcSEcCtD
Trifluridine—TK1—Metabolism—CAV1—prostate cancer	1.54e-05	0.000363	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—CYP19A1—prostate cancer	1.54e-05	0.000363	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—SLC22A3—prostate cancer	1.52e-05	0.000359	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—HSD3B1—prostate cancer	1.52e-05	0.000359	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—RXRA—prostate cancer	1.49e-05	0.00035	CbGpPWpGaD
Trifluridine—Hypersensitivity—Docetaxel—prostate cancer	1.47e-05	0.00554	CcSEcCtD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	1.47e-05	0.000347	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	1.47e-05	0.000346	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—GSTA4—prostate cancer	1.46e-05	0.000344	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—TBXAS1—prostate cancer	1.46e-05	0.000344	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—PRKACB—prostate cancer	1.46e-05	0.000343	CbGpPWpGaD
Trifluridine—Vision blurred—Doxorubicin—prostate cancer	1.44e-05	0.00542	CcSEcCtD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	1.44e-05	0.000339	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—COMT—prostate cancer	1.43e-05	0.000337	CbGpPWpGaD
Trifluridine—Nausea—Etoposide—prostate cancer	1.43e-05	0.00538	CcSEcCtD
Trifluridine—Hypersensitivity—Capecitabine—prostate cancer	1.43e-05	0.00537	CcSEcCtD
Trifluridine—TYMP—Metabolism—GSTP1—prostate cancer	1.43e-05	0.000336	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—GSTA2—prostate cancer	1.42e-05	0.000335	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—ABCG5—prostate cancer	1.4e-05	0.000331	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—SULT1A1—prostate cancer	1.4e-05	0.000331	CbGpPWpGaD
Trifluridine—TK1—Metabolism—PIK3CG—prostate cancer	1.4e-05	0.000331	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—ITPR1—prostate cancer	1.4e-05	0.00033	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—TERT—prostate cancer	1.37e-05	0.000324	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—NCOA2—prostate cancer	1.37e-05	0.000323	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—GSTA1—prostate cancer	1.37e-05	0.000323	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	1.36e-05	0.00032	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—NAT2—prostate cancer	1.36e-05	0.00032	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—HSD3B2—prostate cancer	1.36e-05	0.00032	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—GSTO1—prostate cancer	1.36e-05	0.00032	CbGpPWpGaD
Trifluridine—TK1—Metabolism—INS—prostate cancer	1.33e-05	0.000313	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—TYMS—prostate cancer	1.32e-05	0.000312	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—GSTM1—prostate cancer	1.31e-05	0.000309	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—SLC5A5—prostate cancer	1.31e-05	0.000308	CbGpPWpGaD
Trifluridine—TK1—Metabolism—CREBBP—prostate cancer	1.3e-05	0.000306	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—LRP2—prostate cancer	1.3e-05	0.000306	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—CYP2C18—prostate cancer	1.3e-05	0.000306	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PLCB2—prostate cancer	1.3e-05	0.000306	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—LPL—prostate cancer	1.29e-05	0.000303	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—P4HB—prostate cancer	1.28e-05	0.0003	CbGpPWpGaD
Trifluridine—Hypersensitivity—Prednisone—prostate cancer	1.27e-05	0.00478	CcSEcCtD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	1.25e-05	0.000294	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—CYP1A1—prostate cancer	1.24e-05	0.000292	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—SLC22A1—prostate cancer	1.24e-05	0.000292	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—ATM—prostate cancer	1.24e-05	0.000291	CbGpPWpGaD
Trifluridine—TK1—Metabolism—PIK3CD—prostate cancer	1.23e-05	0.000291	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—ERCC2—prostate cancer	1.23e-05	0.00029	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—SULT2A1—prostate cancer	1.21e-05	0.000285	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	1.21e-05	0.000285	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—MED12—prostate cancer	1.19e-05	0.00028	CbGpPWpGaD
Trifluridine—Nausea—Docetaxel—prostate cancer	1.19e-05	0.00447	CcSEcCtD
Trifluridine—TYMS—Metabolism—GNG5—prostate cancer	1.18e-05	0.000278	CbGpPWpGaD
Trifluridine—TK1—Metabolism—NOS3—prostate cancer	1.16e-05	0.000274	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—TP53—prostate cancer	1.16e-05	0.000273	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—MTHFR—prostate cancer	1.16e-05	0.000273	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—NCOA1—prostate cancer	1.16e-05	0.000272	CbGpPWpGaD
Trifluridine—Pain—Epirubicin—prostate cancer	1.15e-05	0.00434	CcSEcCtD
Trifluridine—Nausea—Capecitabine—prostate cancer	1.15e-05	0.00433	CcSEcCtD
Trifluridine—TYMS—Metabolism—NCOA3—prostate cancer	1.14e-05	0.000268	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—PPARA—prostate cancer	1.14e-05	0.000268	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—RXRA—prostate cancer	1.1e-05	0.000259	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—HPGDS—prostate cancer	1.08e-05	0.000255	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—CYP2C19—prostate cancer	1.08e-05	0.000254	CbGpPWpGaD
Trifluridine—TK1—Metabolism—PIK3CB—prostate cancer	1.07e-05	0.000253	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—CAV1—prostate cancer	1.07e-05	0.000252	CbGpPWpGaD
Trifluridine—Pain—Doxorubicin—prostate cancer	1.07e-05	0.00402	CcSEcCtD
Trifluridine—TK1—Metabolism—PTGS2—prostate cancer	1.07e-05	0.000251	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—IL6—prostate cancer	1.06e-05	0.00025	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—ACHE—prostate cancer	1.05e-05	0.000248	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—GSTT1—prostate cancer	1.05e-05	0.000248	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—CYP2A6—prostate cancer	1.04e-05	0.000245	CbGpPWpGaD
Trifluridine—Nausea—Prednisone—prostate cancer	1.02e-05	0.00386	CcSEcCtD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	1.02e-05	0.00024	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—AKR1C3—prostate cancer	1.01e-05	0.000238	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PRKACB—prostate cancer	1.01e-05	0.000237	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—CYP17A1—prostate cancer	9.96e-06	0.000235	CbGpPWpGaD
Trifluridine—Hypersensitivity—Epirubicin—prostate cancer	9.94e-06	0.00374	CcSEcCtD
Trifluridine—TYMP—Metabolism—PIK3CG—prostate cancer	9.72e-06	0.000229	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—NCOA2—prostate cancer	9.49e-06	0.000223	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—CDKN1B—prostate cancer	9.31e-06	0.000219	CbGpPWpGaD
Trifluridine—TK1—Metabolism—PTEN—prostate cancer	9.29e-06	0.000219	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—INS—prostate cancer	9.2e-06	0.000217	CbGpPWpGaD
Trifluridine—Hypersensitivity—Doxorubicin—prostate cancer	9.19e-06	0.00346	CcSEcCtD
Trifluridine—TYMS—Cell Cycle—MDM2—prostate cancer	9.12e-06	0.000215	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—SLC5A5—prostate cancer	9.05e-06	0.000213	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—CREBBP—prostate cancer	9.02e-06	0.000212	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—CCND1—prostate cancer	8.88e-06	0.000209	CbGpPWpGaD
Trifluridine—TK1—Metabolism—EP300—prostate cancer	8.86e-06	0.000209	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—CYP2E1—prostate cancer	8.84e-06	0.000208	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—NQO1—prostate cancer	8.74e-06	0.000206	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—TH—prostate cancer	8.61e-06	0.000203	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—CDKN1A—prostate cancer	8.59e-06	0.000202	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—PIK3CD—prostate cancer	8.55e-06	0.000201	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—CYP3A4—prostate cancer	8.52e-06	0.000201	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—PPARA—prostate cancer	8.4e-06	0.000198	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—CYP1B1—prostate cancer	8.38e-06	0.000197	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—CDKN1B—prostate cancer	8.33e-06	0.000196	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—EP300—prostate cancer	8.18e-06	0.000193	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—GGT1—prostate cancer	8.12e-06	0.000191	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—NOS3—prostate cancer	8.07e-06	0.00019	CbGpPWpGaD
Trifluridine—Nausea—Epirubicin—prostate cancer	8.01e-06	0.00302	CcSEcCtD
Trifluridine—TYMS—Metabolism—NCOA1—prostate cancer	7.99e-06	0.000188	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—CCND1—prostate cancer	7.94e-06	0.000187	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—CYP19A1—prostate cancer	7.88e-06	0.000186	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—CDKN1A—prostate cancer	7.68e-06	0.000181	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—RXRA—prostate cancer	7.6e-06	0.000179	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—PIK3CB—prostate cancer	7.45e-06	0.000176	CbGpPWpGaD
Trifluridine—Nausea—Doxorubicin—prostate cancer	7.41e-06	0.00279	CcSEcCtD
Trifluridine—TYMP—Metabolism—PTGS2—prostate cancer	7.38e-06	0.000174	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—COMT—prostate cancer	7.32e-06	0.000173	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—EP300—prostate cancer	7.31e-06	0.000172	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—GSTP1—prostate cancer	7.29e-06	0.000172	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—ITPR1—prostate cancer	7.17e-06	0.000169	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—MYC—prostate cancer	7.13e-06	0.000168	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—GSTM1—prostate cancer	6.7e-06	0.000158	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—CREBBP—prostate cancer	6.67e-06	0.000157	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—LPL—prostate cancer	6.58e-06	0.000155	CbGpPWpGaD
Trifluridine—TK1—Metabolism—PIK3CA—prostate cancer	6.55e-06	0.000154	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—PTEN—prostate cancer	6.44e-06	0.000152	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—MYC—prostate cancer	6.37e-06	0.00015	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—CYP1A1—prostate cancer	6.35e-06	0.00015	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—ERCC2—prostate cancer	6.3e-06	0.000148	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—EP300—prostate cancer	6.14e-06	0.000145	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—MTHFR—prostate cancer	5.92e-06	0.000139	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PPARA—prostate cancer	5.81e-06	0.000137	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—CAV1—prostate cancer	5.46e-06	0.000129	CbGpPWpGaD
Trifluridine—TK1—Metabolism—AKT1—prostate cancer	5.35e-06	0.000126	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—TP53—prostate cancer	5.23e-06	0.000123	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PIK3CG—prostate cancer	4.97e-06	0.000117	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—INS—prostate cancer	4.71e-06	0.000111	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—CREBBP—prostate cancer	4.61e-06	0.000109	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—PIK3CA—prostate cancer	4.54e-06	0.000107	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PIK3CD—prostate cancer	4.37e-06	0.000103	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—NOS3—prostate cancer	4.13e-06	9.73e-05	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PIK3CB—prostate cancer	3.81e-06	8.98e-05	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PTGS2—prostate cancer	3.78e-06	8.9e-05	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—AKT1—prostate cancer	3.71e-06	8.74e-05	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PTEN—prostate cancer	3.29e-06	7.76e-05	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—EP300—prostate cancer	3.14e-06	7.4e-05	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PIK3CA—prostate cancer	2.32e-06	5.47e-05	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—AKT1—prostate cancer	1.9e-06	4.47e-05	CbGpPWpGaD
